Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $8,108 - $9,193
-169 Reduced 3.46%
4,722 $256,000
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $15,755 - $18,801
-325 Reduced 6.23%
4,891 $250,000
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $10,014 - $11,198
173 Added 3.43%
5,216 $302,000
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $1,210 - $1,344
19 Added 0.38%
5,043 $322,000
Q1 2023

Apr 24, 2023

SELL
$65.71 - $74.53 $132,142 - $149,879
-2,011 Reduced 28.59%
5,024 $348,000
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $42,594 - $50,437
622 Added 9.7%
7,035 $439,000
Q3 2022

Oct 24, 2022

SELL
$0.13 - $76.84 $45 - $26,740
-348 Reduced 5.15%
6,413 $456,000
Q2 2022

Jul 15, 2022

SELL
$72.62 - $79.98 $17,210 - $18,955
-237 Reduced 3.39%
6,761 $521,000
Q1 2022

Apr 07, 2022

SELL
$61.48 - $73.72 $2,274 - $2,727
-37 Reduced 0.53%
6,998 $511,000
Q4 2021

Jan 07, 2022

BUY
$53.63 - $62.52 $7,293 - $8,502
136 Added 1.97%
7,035 $439,000
Q3 2021

Oct 05, 2021

SELL
$59.17 - $69.31 $946 - $1,108
-16 Reduced 0.23%
6,899 $408,000
Q2 2021

Aug 02, 2021

BUY
$61.91 - $67.42 $16,282 - $17,731
263 Added 3.95%
6,915 $471,000
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $39,520 - $44,448
666 Added 11.13%
6,652 $420,000
Q4 2020

Jan 12, 2021

BUY
$57.74 - $65.43 $34,817 - $39,454
603 Added 11.2%
5,986 $389,000
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $3,962 - $4,391
-69 Reduced 1.27%
5,383 $325,000
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $3,892 - $4,550
71 Added 1.32%
5,452 $321,000
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $46 - $67
1 Added 0.02%
5,381 $300,000
Q4 2019

Jan 23, 2020

BUY
$49.21 - $64.19 $264,749 - $345,342
5,380 New
5,380 $345,000
Q4 2018

Jan 30, 2019

SELL
$48.76 - $63.23 $17,748 - $23,015
-364 Closed
0 $0
Q3 2018

Oct 10, 2018

BUY
$55.19 - $62.25 $55 - $62
1 Added 0.28%
364 $23,000
Q2 2018

Aug 22, 2018

BUY
$50.53 - $62.98 $2,526 - $3,149
50 Added 15.97%
363 $20,000
Q1 2018

Apr 24, 2018

BUY
$59.92 - $68.98 $18,754 - $21,590
313 New
313 $20,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mc Adam, LLC Portfolio

Follow Mc Adam, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.